Sfoglia per Autore
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression.
1991-01-01 Barosi, G; Buratti, A; Costa, A; Liberato, L. N.; Balduini, Carlo; Cazzola, Mario; Rosti, V; Magrini, Umberto; Ascari, Edoardo
Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
1991-01-01 Bergamaschi, G; Cazzola, Mario; Rosti, V; Carlo Stella, C; Santini, V; Ponchio, L; Peverali, Fa; Della Valle, G; Rossi Ferrini, P; Ascari, E.
Anemie diseritropoietiche congenite.
1992-01-01 Cazzola, Mario
Policitemia vera.
1992-01-01 Cazzola, Mario
Anemie sideroblastiche.
1992-01-01 Cazzola, Mario
Anemia delle malattie croniche.
1992-01-01 Cazzola, Mario
Eritrociti.
1992-01-01 Cazzola, Mario
Anemia delle epatopatie.
1992-01-01 Cazzola, Mario
Anemia associata ad endocrinopatie.
1992-01-01 Cazzola, Mario
Fisiopatologia dell'eritrocito.
1992-01-01 Cazzola, Mario
Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
1992-01-01 Ponchio, L; Beguin, Y; Farina, G; Pedrazzoli, P; Pedrotti, C; Poggi, G; Rosti, V; Bergamaschi, G; Battistel, V; Cazzola, Mario
Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.
1992-01-01 Locatelli, Franco; Pedrazzoli, P; Barosi, G; Zecca, M; Porta, F; Liberato, L; Gambarana, D; Nespoli, L; Cazzola, Mario
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.
1992-01-01 Cazzola, Mario; Ponchio, L; Beguin, Y; Rosti, V; Bergamaschi, G; Liberato, Nl; Fregoni, V; Nalli, G; Barosi, G; Ascari, E.
Diagnostic approach to the myelodysplastic syndromes.
1992-01-01 Cazzola, Mario; Ponchio, L; Rosti, V; Farina, G; Pedrotti, C; Bergamaschi, G.
c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
1992-01-01 Rosti, V; Bergamaschi, G; Ponchio, L; Cazzola, Mario
Anemia postemorragica.
1992-01-01 Cazzola, Mario
Eritrocitosi.
1992-01-01 Cazzola, Mario
Disordini del metabolismo del ferro.
1992-01-01 Cazzola, Mario
Sindromi talassemiche.
1992-01-01 Cazzola, Mario
New tools for clinical evaluation of erythron function in man.
1992-01-01 Cazzola, Mario; Beguin, Y.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. | 1-gen-1991 | Barosi, G; Buratti, A; Costa, A; Liberato, L. N.; Balduini, Carlo; Cazzola, Mario; Rosti, V; Magrini, Umberto; Ascari, Edoardo | |
Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia. | 1-gen-1991 | Bergamaschi, G; Cazzola, Mario; Rosti, V; Carlo Stella, C; Santini, V; Ponchio, L; Peverali, Fa; Della Valle, G; Rossi Ferrini, P; Ascari, E. | |
Anemie diseritropoietiche congenite. | 1-gen-1992 | Cazzola, Mario | |
Policitemia vera. | 1-gen-1992 | Cazzola, Mario | |
Anemie sideroblastiche. | 1-gen-1992 | Cazzola, Mario | |
Anemia delle malattie croniche. | 1-gen-1992 | Cazzola, Mario | |
Eritrociti. | 1-gen-1992 | Cazzola, Mario | |
Anemia delle epatopatie. | 1-gen-1992 | Cazzola, Mario | |
Anemia associata ad endocrinopatie. | 1-gen-1992 | Cazzola, Mario | |
Fisiopatologia dell'eritrocito. | 1-gen-1992 | Cazzola, Mario | |
Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia. | 1-gen-1992 | Ponchio, L; Beguin, Y; Farina, G; Pedrazzoli, P; Pedrotti, C; Poggi, G; Rosti, V; Bergamaschi, G; Battistel, V; Cazzola, Mario | |
Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation. | 1-gen-1992 | Locatelli, Franco; Pedrazzoli, P; Barosi, G; Zecca, M; Porta, F; Liberato, L; Gambarana, D; Nespoli, L; Cazzola, Mario | |
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. | 1-gen-1992 | Cazzola, Mario; Ponchio, L; Beguin, Y; Rosti, V; Bergamaschi, G; Liberato, Nl; Fregoni, V; Nalli, G; Barosi, G; Ascari, E. | |
Diagnostic approach to the myelodysplastic syndromes. | 1-gen-1992 | Cazzola, Mario; Ponchio, L; Rosti, V; Farina, G; Pedrotti, C; Bergamaschi, G. | |
c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers. | 1-gen-1992 | Rosti, V; Bergamaschi, G; Ponchio, L; Cazzola, Mario | |
Anemia postemorragica. | 1-gen-1992 | Cazzola, Mario | |
Eritrocitosi. | 1-gen-1992 | Cazzola, Mario | |
Disordini del metabolismo del ferro. | 1-gen-1992 | Cazzola, Mario | |
Sindromi talassemiche. | 1-gen-1992 | Cazzola, Mario | |
New tools for clinical evaluation of erythron function in man. | 1-gen-1992 | Cazzola, Mario; Beguin, Y. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile